id	sid	eid	entity	type
admet-1622	1	1	3d	CARDINAL
admet-1622	1	2	https://doi.org/10.5599/admet.1622 33 admet	ORG
admet-1622	1	3	11(1	CARDINAL
admet-1622	1	4	2023	CARDINAL
admet-1622	1	5	33	CARDINAL
admet-1622	1	6	issn	PERSON
admet-1622	1	7	1848-7718	DATE
admet-1622	1	8	3d	CARDINAL
admet-1622	1	9	abu t.m	PERSON
admet-1622	1	10	serajuddin department of pharmaceutical sciences	ORG
admet-1622	1	11	st	GPE
admet-1622	1	12	john’s university	ORG
admet-1622	1	13	8000	CARDINAL
admet-1622	1	14	ny 11439	ORG
admet-1622	1	15	november 27	DATE
admet-1622	1	16	2022	CARDINAL
admet-1622	1	17	december 13	DATE
admet-1622	1	18	2022	CARDINAL
admet-1622	1	19	january 01	DATE
admet-1622	1	20	2023	CARDINAL
admet-1622	1	21	3d	CARDINAL
admet-1622	1	22	fda	ORG
admet-1622	1	23	2015	DATE
admet-1622	1	24	3d	CARDINAL
admet-1622	2	1	3d	CARDINAL
admet-1622	2	2	3d	CARDINAL
admet-1622	2	3	first	ORDINAL
admet-1622	2	4	3d	CARDINAL
admet-1622	3	1	3d	CARDINAL
admet-1622	4	1	3d	CARDINAL
admet-1622	5	1	3d	CARDINAL
admet-1622	6	1	two	CARDINAL
admet-1622	6	2	3d	CARDINAL
admet-1622	6	3	one	CARDINAL
admet-1622	6	4	3d	CARDINAL
admet-1622	7	1	3d	CARDINAL
admet-1622	8	1	2023	CARDINAL
admet-1622	10	1	3d	CARDINAL
admet-1622	10	2	3d	CARDINAL
admet-1622	10	3	three	CARDINAL
admet-1622	10	4	3d	CARDINAL
admet-1622	11	1	1	CARDINAL
admet-1622	12	1	2	CARDINAL
admet-1622	13	1	3d	CARDINAL
admet-1622	13	2	https://doi.org/10.5599/admet.1622 https://doi.org/10.5599/admet.1622 http://www.pub.iapchem.org/ojs/index.php/admet/index mailto:serajuda@stjohns.edu	GPE
admet-1622	13	3	abu t.m	PERSON
admet-1622	14	1	serajuddin admet &	ORG
admet-1622	14	2	11(1	CARDINAL
admet-1622	14	3	2023	CARDINAL
admet-1622	14	4	33	CARDINAL
admet-1622	14	5	55 34	CARDINAL
admet-1622	14	6	3d	CARDINAL
admet-1622	14	7	us	GPE
admet-1622	14	8	2015	DATE
admet-1622	14	9	3	CARDINAL
admet-1622	14	10	3d	CARDINAL
admet-1622	14	11	recent years	DATE
admet-1622	15	1	4	CARDINAL
admet-1622	15	2	5	CARDINAL
admet-1622	16	1	3d	CARDINAL
admet-1622	16	2	6-12	CARDINAL
admet-1622	17	1	3d	CARDINAL
admet-1622	17	2	sse	ORG
admet-1622	17	3	stereolithography	ORG
admet-1622	17	4	sla	ORG
admet-1622	17	5	1,11	CARDINAL
admet-1622	18	1	3d	CARDINAL
admet-1622	19	1	3d	CARDINAL
admet-1622	20	1	13,14	CARDINAL
admet-1622	21	1	3d	CARDINAL
admet-1622	21	2	3d	CARDINAL
admet-1622	24	1	3d	CARDINAL
admet-1622	26	1	3d	CARDINAL
admet-1622	29	1	3d	CARDINAL
admet-1622	30	1	3d	CARDINAL
admet-1622	31	1	3d	CARDINAL
admet-1622	32	1	one	CARDINAL
admet-1622	32	2	3dprinting	CARDINAL
admet-1622	33	1	17,18	CARDINAL
admet-1622	33	2	3d	CARDINAL
admet-1622	34	1	two	CARDINAL
admet-1622	34	2	one	CARDINAL
admet-1622	34	3	3d	CARDINAL
admet-1622	34	4	solanki et al	PERSON
admet-1622	35	1	19	CARDINAL
admet-1622	35	2	two	CARDINAL
admet-1622	35	3	20,21	CARDINAL
admet-1622	35	4	11(1	CARDINAL
admet-1622	35	5	2023	CARDINAL
admet-1622	35	6	33	CARDINAL
admet-1622	35	7	3d	CARDINAL
admet-1622	36	1	3d	CARDINAL
admet-1622	36	2	solanki et al	PERSON
admet-1622	37	1	19	CARDINAL
admet-1622	38	1	20,21	CARDINAL
admet-1622	38	2	3d	CARDINAL
admet-1622	39	1	3d	CARDINAL
admet-1622	39	2	3d	CARDINAL
admet-1622	40	1	3d	CARDINAL
admet-1622	41	1	1	CARDINAL
admet-1622	41	2	3d	CARDINAL
admet-1622	42	1	1a	CARDINAL
admet-1622	42	2	1b	CARDINAL
admet-1622	42	3	1	CARDINAL
admet-1622	43	1	3d	CARDINAL
admet-1622	43	2	3d	CARDINAL
admet-1622	45	1	ilyes	ORG
admet-1622	46	1	22	CARDINAL
admet-1622	48	1	1a	CARDINAL
admet-1622	48	2	first	ORDINAL
admet-1622	48	3	3d	CARDINAL
admet-1622	51	1	serajuddin admet &	ORG
admet-1622	51	2	11(1	CARDINAL
admet-1622	51	3	2023	CARDINAL
admet-1622	51	4	33	CARDINAL
admet-1622	53	1	tg	ORG
admet-1622	55	1	3d	CARDINAL
admet-1622	57	1	1b	CARDINAL
admet-1622	59	1	25	CARDINAL
admet-1622	60	1	one	CARDINAL
admet-1622	60	2	26	CARDINAL
admet-1622	62	1	henry et al	PERSON
admet-1622	63	1	27	CARDINAL
admet-1622	63	2	3d	CARDINAL
admet-1622	64	1	3d	CARDINAL
admet-1622	65	1	3d	CARDINAL
admet-1622	66	1	approximately 3	CARDINAL
admet-1622	66	2	4	CARDINAL
admet-1622	67	1	28	CARDINAL
admet-1622	68	1	3d	CARDINAL
admet-1622	69	1	37	CARDINAL
admet-1622	69	2	3d	CARDINAL
admet-1622	69	3	pereira et al	PERSON
admet-1622	70	1	29	CARDINAL
admet-1622	70	2	28 (74 %	PERCENT
admet-1622	71	1	3d	CARDINAL
admet-1622	71	2	30	CARDINAL
admet-1622	73	1	3d	CARDINAL
admet-1622	75	1	3d	CARDINAL
admet-1622	75	2	31	CARDINAL
admet-1622	76	1	one	CARDINAL
admet-1622	76	2	3d	CARDINAL
admet-1622	76	3	solanki et al	PERSON
admet-1622	77	1	19	CARDINAL
admet-1622	77	2	kollidon®	ORG
admet-1622	77	3	va64	PRODUCT
admet-1622	77	4	15cp	DATE
admet-1622	77	5	1:1	CARDINAL
admet-1622	77	6	two	CARDINAL
admet-1622	77	7	parikh et al	PERSON
admet-1622	78	1	32	CARDINAL
admet-1622	79	1	kollidon®	ORG
admet-1622	79	2	va64	PRODUCT
admet-1622	79	3	15cp	DATE
admet-1622	79	4	1:1	CARDINAL
admet-1622	79	5	kollidon	NORP
admet-1622	79	6	approximately 20	CARDINAL
admet-1622	79	7	15 percent	PERCENT
admet-1622	80	1	wei et al	PERSON
admet-1622	81	1	33	CARDINAL
admet-1622	81	2	10 %	PERCENT
admet-1622	81	3	w/w	EVENT
admet-1622	81	4	up to 20 %	PERCENT
admet-1622	82	1	11(1	CARDINAL
admet-1622	82	2	2023	CARDINAL
admet-1622	82	3	33	CARDINAL
admet-1622	82	4	3d	CARDINAL
admet-1622	82	5	https://doi.org/10.5599/admet.1622 37	ORG
admet-1622	83	1	3d	CARDINAL
admet-1622	84	1	34,35	CARDINAL
admet-1622	86	1	58	CARDINAL
admet-1622	86	2	3d	CARDINAL
admet-1622	86	3	cailleaux et al	PERSON
admet-1622	87	1	26	CARDINAL
admet-1622	87	2	50	CARDINAL
admet-1622	87	3	100 to 210 °	QUANTITY
admet-1622	87	4	140-180 °	QUANTITY
admet-1622	88	1	47	CARDINAL
admet-1622	88	2	150	CARDINAL
admet-1622	88	3	around 200°	QUANTITY
admet-1622	89	1	3d	CARDINAL
admet-1622	91	1	3d	CARDINAL
admet-1622	92	1	3d	CARDINAL
admet-1622	96	1	26	CARDINAL
admet-1622	96	2	56	CARDINAL
admet-1622	96	3	3d	CARDINAL
admet-1622	96	4	43	CARDINAL
admet-1622	96	5	4	CARDINAL
admet-1622	96	6	9	CARDINAL
admet-1622	97	1	17,18	CARDINAL
admet-1622	98	1	3d	CARDINAL
admet-1622	99	1	3d	CARDINAL
admet-1622	103	1	2014	DATE
admet-1622	103	2	the food and drug administration	ORG
admet-1622	103	3	fda	ORG
admet-1622	103	4	us	GPE
admet-1622	103	5	europe	LOC
admet-1622	103	6	arzu selen	PERSON
admet-1622	103	7	fda	ORG
admet-1622	103	8	18	CARDINAL
admet-1622	104	1	17	CARDINAL
admet-1622	105	1	https://doi.org/10.5599/admet.1622 abu	PERSON
admet-1622	106	1	serajuddin admet &	ORG
admet-1622	106	2	11(1	CARDINAL
admet-1622	106	3	2023	CARDINAL
admet-1622	106	4	33	CARDINAL
admet-1622	106	5	55 38	CARDINAL
admet-1622	106	6	four	CARDINAL
admet-1622	106	7	2	CARDINAL
admet-1622	106	8	2	CARDINAL
admet-1622	106	9	four	CARDINAL
admet-1622	108	1	17	CARDINAL
admet-1622	109	1	1	CARDINAL
admet-1622	109	2	2	CARDINAL
admet-1622	110	1	3	CARDINAL
admet-1622	111	1	4	CARDINAL
admet-1622	113	1	1	CARDINAL
admet-1622	113	2	2	CARDINAL
admet-1622	113	3	3	CARDINAL
admet-1622	114	1	4	CARDINAL
admet-1622	116	1	3d	CARDINAL
admet-1622	117	1	11(1	CARDINAL
admet-1622	117	2	2023	CARDINAL
admet-1622	117	3	33	CARDINAL
admet-1622	117	4	3d	CARDINAL
admet-1622	117	5	39	CARDINAL
admet-1622	117	6	3d	CARDINAL
admet-1622	117	7	3d	CARDINAL
admet-1622	118	1	3d	CARDINAL
admet-1622	119	1	3d	CARDINAL
admet-1622	121	1	polyvinylpyrrolidone	ORG
admet-1622	121	2	3d	CARDINAL
admet-1622	122	1	19	CARDINAL
admet-1622	124	1	36	CARDINAL
admet-1622	124	2	3d	CARDINAL
admet-1622	125	1	celluloses	PERSON
admet-1622	125	2	3d	CARDINAL
admet-1622	125	3	3d	CARDINAL
admet-1622	125	4	sse	ORG
admet-1622	126	1	3d	CARDINAL
admet-1622	126	2	dimethyl aminoethyl methacrylate	ORG
admet-1622	126	3	2:1:1	CARDINAL
admet-1622	127	1	37	CARDINAL
admet-1622	129	1	1	CARDINAL
admet-1622	129	2	3d	CARDINAL
admet-1622	129	3	0.1	CARDINAL
admet-1622	129	4	hcl	PERSON
admet-1622	129	5	ph~1.1	PERSON
admet-1622	129	6	38-40	CARDINAL
admet-1622	130	1	0.1	CARDINAL
admet-1622	130	2	41,42	CARDINAL
admet-1622	131	1	6.8	CARDINAL
admet-1622	133	1	2	CARDINAL
admet-1622	133	2	5	CARDINAL
admet-1622	133	3	fed	ORG
admet-1622	133	4	45	CARDINAL
admet-1622	133	5	3d	CARDINAL
admet-1622	134	1	e.	PERSON
admet-1622	134	2	52 °	QUANTITY
admet-1622	136	1	yang et al	PERSON
admet-1622	137	1	46	CARDINAL
admet-1622	137	2	37.5-50 %	PERCENT
admet-1622	138	1	3d	CARDINAL
admet-1622	138	2	https://doi.org/10.5599/admet.1622 abu t.m	ORG
admet-1622	138	3	serajuddin admet &	ORG
admet-1622	138	4	11(1	CARDINAL
admet-1622	138	5	2023	CARDINAL
admet-1622	138	6	33	CARDINAL
admet-1622	138	7	solanki et al	PERSON
admet-1622	139	1	19	CARDINAL
admet-1622	141	1	kollidon®	ORG
admet-1622	141	2	va64	PRODUCT
admet-1622	141	3	15	CARDINAL
admet-1622	141	4	1:1 w	MONEY
admet-1622	142	1	1	CARDINAL
admet-1622	142	2	6.8	CARDINAL
admet-1622	143	1	kollidon®	ORG
admet-1622	143	2	va64	PRODUCT
admet-1622	143	3	15	CARDINAL
admet-1622	144	1	3d	CARDINAL
admet-1622	145	1	takka	PERSON
admet-1622	145	2	47	CARDINAL
admet-1622	145	3	20 %	PERCENT
admet-1622	145	4	kollidon	ORG
admet-1622	145	5	va64,	GPE
admet-1622	145	6	20 %	PERCENT
admet-1622	145	7	34 %	PERCENT
admet-1622	145	8	15 %	PERCENT
admet-1622	145	9	80	CARDINAL
admet-1622	145	10	44/14	CARDINAL
admet-1622	145	11	gelucire	ORG
admet-1622	145	12	48/16	PRODUCT
admet-1622	145	13	triacetin	ORG
admet-1622	146	1	up to 80 %	PERCENT
admet-1622	146	2	1	CARDINAL
admet-1622	146	3	50 %	PERCENT
admet-1622	147	1	3d	CARDINAL
admet-1622	148	1	okwuosa et al	PERSON
admet-1622	149	1	48	CARDINAL
admet-1622	149	2	30 min	DATE
admet-1622	149	3	50 %	PERCENT
admet-1622	149	4	40,000	CARDINAL
admet-1622	149	5	12.5 %	PERCENT
admet-1622	149	6	triethyl citrate	ORG
admet-1622	149	7	27.5 %	PERCENT
admet-1622	149	8	10 %	PERCENT
admet-1622	153	1	sadia et al	PERSON
admet-1622	154	1	49	CARDINAL
admet-1622	154	2	80 %	PERCENT
admet-1622	154	3	four	CARDINAL
admet-1622	154	4	5	CARDINAL
admet-1622	154	5	30 min	QUANTITY
admet-1622	159	1	50	CARDINAL
admet-1622	159	2	13.5 %	PERCENT
admet-1622	159	3	9.5 %	PERCENT
admet-1622	159	4	3d	CARDINAL
admet-1622	160	1	30	CARDINAL
admet-1622	161	1	38,43,51,52	CARDINAL
admet-1622	163	1	38	CARDINAL
admet-1622	163	2	70:30	TIME
admet-1622	163	3	0.25	CARDINAL
admet-1622	163	4	0.1m	QUANTITY
admet-1622	163	5	20 min	DATE
admet-1622	164	1	130 °	QUANTITY
admet-1622	165	1	70:30	TIME
admet-1622	166	1	1.2	CARDINAL
admet-1622	166	2	11(1	CARDINAL
admet-1622	166	3	2023	CARDINAL
admet-1622	166	4	33	CARDINAL
admet-1622	166	5	3d	CARDINAL
admet-1622	166	6	5.5 to 7.5	CARDINAL
admet-1622	167	1	gultekin et al	PERSON
admet-1622	168	1	38	CARDINAL
admet-1622	169	1	43	CARDINAL
admet-1622	170	1	3d	CARDINAL
admet-1622	170	2	10 %	PERCENT
admet-1622	170	3	50 %	PERCENT
admet-1622	170	4	15 %	PERCENT
admet-1622	170	5	15 %	PERCENT
admet-1622	170	6	80	DATE
admet-1622	170	7	10 %	PERCENT
admet-1622	170	8	4000	CARDINAL
admet-1622	171	1	3d	CARDINAL
admet-1622	172	1	1.2	CARDINAL
admet-1622	172	2	30	CARDINAL
admet-1622	172	3	6.8	CARDINAL
admet-1622	172	4	6h	CARDINAL
admet-1622	173	1	1.2	CARDINAL
admet-1622	173	2	6.8	CARDINAL
admet-1622	174	1	400	CARDINAL
admet-1622	175	1	3d	CARDINAL
admet-1622	176	1	kollamaram et al	PERSON
admet-1622	177	1	53	CARDINAL
admet-1622	177	2	3d	CARDINAL
admet-1622	177	3	20 %	PERCENT
admet-1622	177	4	1500	CARDINAL
admet-1622	177	5	10 %	PERCENT
admet-1622	177	6	3 %	PERCENT
admet-1622	177	7	ramipril (drug	ORG
admet-1622	177	8	65 %	PERCENT
admet-1622	177	9	kollidon	ORG
admet-1622	177	10	va64	PERSON
admet-1622	177	11	kollidon®	ORG
admet-1622	177	12	va64	PERSON
admet-1622	177	13	kollidon®	ORG
admet-1622	178	1	30 min	TIME
admet-1622	178	2	65-70 °	QUANTITY
admet-1622	178	3	90 °	QUANTITY
admet-1622	179	1	109 °	QUANTITY
admet-1622	179	2	54	CARDINAL
admet-1622	179	3	1500	CARDINAL
admet-1622	180	1	43	CARDINAL
admet-1622	180	2	kollidon®	ORG
admet-1622	180	3	va64	PERSON
admet-1622	180	4	kollidon®	ORG
admet-1622	181	1	3 %	PERCENT
admet-1622	181	2	20 %	PERCENT
admet-1622	182	1	3d	CARDINAL
admet-1622	182	2	croscarmellose sodium	PERSON
admet-1622	182	3	kollidon®	ORG
admet-1622	182	4	55	CARDINAL
admet-1622	183	1	58 %	PERCENT
admet-1622	183	2	5	CARDINAL
admet-1622	183	3	2	CARDINAL
admet-1622	185	1	shi et al	PERSON
admet-1622	186	1	56	CARDINAL
admet-1622	186	2	6000	CARDINAL
admet-1622	186	3	rlpo	PERSON
admet-1622	186	4	k100m	PERSON
admet-1622	186	5	kollidon®	ORG
admet-1622	186	6	va64	PRODUCT
admet-1622	186	7	3d	CARDINAL
admet-1622	187	1	3d	CARDINAL
admet-1622	188	1	24	CARDINAL
admet-1622	189	1	3d	CARDINAL
admet-1622	190	1	krueger et al	PERSON
admet-1622	191	1	57	CARDINAL
admet-1622	191	2	https://doi.org/10.5599/admet.1622 abu	FAC
admet-1622	191	3	serajuddin admet &	ORG
admet-1622	191	4	11(1	CARDINAL
admet-1622	191	5	2023	CARDINAL
admet-1622	191	6	33	CARDINAL
admet-1622	196	1	one	CARDINAL
admet-1622	196	2	wei et al	PERSON
admet-1622	197	1	33	CARDINAL
admet-1622	197	2	3350	CARDINAL
admet-1622	197	3	8000	CARDINAL
admet-1622	200	1	3d	CARDINAL
admet-1622	201	1	one	CARDINAL
admet-1622	202	1	3	CARDINAL
admet-1622	202	2	3	CARDINAL
admet-1622	204	1	3dprinted	CARDINAL
admet-1622	206	1	3d	CARDINAL
admet-1622	206	2	less than 10 % to 100 %	PERCENT
admet-1622	206	3	30 % and 80 %	PERCENT
admet-1622	206	4	30 % and 80 %	PERCENT
admet-1622	206	5	the remaining 70 % and 20 %	PERCENT
admet-1622	206	6	100 %	PERCENT
admet-1622	207	1	58	CARDINAL
admet-1622	208	1	3d	CARDINAL
admet-1622	209	1	11(1	CARDINAL
admet-1622	209	2	2023	CARDINAL
admet-1622	209	3	33	CARDINAL
admet-1622	209	4	3d	CARDINAL
admet-1622	209	5	https://doi.org/10.5599/admet.1622 43	ORG
admet-1622	209	6	2-(4-isobutylphenyl	QUANTITY
admet-1622	209	7	3d	CARDINAL
admet-1622	209	8	thakkar et al	PERSON
admet-1622	210	1	58	CARDINAL
admet-1622	210	2	80 %	PERCENT
admet-1622	210	3	6.8	CARDINAL
admet-1622	210	4	80 %	PERCENT
admet-1622	211	1	60	CARDINAL
admet-1622	211	2	40	DATE
admet-1622	211	3	20 %	PERCENT
admet-1622	212	1	20 %	PERCENT
admet-1622	212	2	80 %	PERCENT
admet-1622	213	1	hpmcas-mg	EVENT
admet-1622	213	2	6.8	CARDINAL
admet-1622	214	1	zhang et al	PERSON
admet-1622	215	1	59	CARDINAL
admet-1622	215	2	3-4	DATE
admet-1622	215	3	3d	CARDINAL
admet-1622	215	4	25 to 75 %	PERCENT
admet-1622	217	1	60	CARDINAL
admet-1622	217	2	3d	CARDINAL
admet-1622	218	1	10 %	PERCENT
admet-1622	218	2	6	CARDINAL
admet-1622	218	3	only about 70 %	PERCENT
admet-1622	218	4	50 and 90 %	PERCENT
admet-1622	220	1	one	CARDINAL
admet-1622	221	1	3-ii	QUANTITY
admet-1622	221	2	arafat et al	PERSON
admet-1622	222	1	61	CARDINAL
admet-1622	222	2	50:45:5	CARDINAL
admet-1622	222	3	3d	CARDINAL
admet-1622	222	4	9	CARDINAL
admet-1622	222	5	3	CARDINAL
admet-1622	222	6	0 to	QUANTITY
admet-1622	222	7	1.2 mm	QUANTITY
admet-1622	224	1	almost 2	CARDINAL
admet-1622	224	2	0.2 mm	QUANTITY
admet-1622	225	1	1 mm	QUANTITY
admet-1622	225	2	80 %	PERCENT
admet-1622	225	3	30 min	DATE
admet-1622	226	1	sadia et al	ORG
admet-1622	227	1	62	CARDINAL
admet-1622	227	2	3d	CARDINAL
admet-1622	228	1	3-iii	QUANTITY
admet-1622	229	1	0.2	CARDINAL
admet-1622	229	2	0.4	CARDINAL
admet-1622	229	3	0.6	CARDINAL
admet-1622	229	4	0.8	CARDINAL
admet-1622	229	5	1.0 mm	QUANTITY
admet-1622	230	1	over 80 %	PERCENT
admet-1622	230	2	30 min	DATE
admet-1622	230	3	1.2	CARDINAL
admet-1622	231	1	0.6 mm	QUANTITY
admet-1622	232	1	triethyl citrate	ORG
admet-1622	232	2	12.5:46.75:25.37:3.25	CARDINAL
admet-1622	232	3	3d	CARDINAL
admet-1622	234	1	e. additionally	PERSON
admet-1622	234	2	one	CARDINAL
admet-1622	235	1	isreb et al	PERSON
admet-1622	236	1	63	CARDINAL
admet-1622	236	2	0.5	CARDINAL
admet-1622	236	3	1	CARDINAL
admet-1622	236	4	1.5	CARDINAL
admet-1622	237	1	3-iv	CARDINAL
admet-1622	238	1	30:35:35 w	MONEY
admet-1622	238	2	6000	CARDINAL
admet-1622	238	3	100,000 to 900,000	CARDINAL
admet-1622	239	1	1 mm	QUANTITY
admet-1622	239	2	over 80 %	PERCENT
admet-1622	239	3	3dhttps://doi.org/10.5599/admet.1622	CARDINAL
admet-1622	240	1	serajuddin admet &	ORG
admet-1622	240	2	11(1	CARDINAL
admet-1622	240	3	2023	CARDINAL
admet-1622	240	4	33	CARDINAL
admet-1622	240	5	30 min	QUANTITY
admet-1622	240	6	1.2	CARDINAL
admet-1622	242	1	khaled et al	PERSON
admet-1622	243	1	64	CARDINAL
admet-1622	243	2	3d	CARDINAL
admet-1622	244	1	65,66	CARDINAL
admet-1622	246	1	65	CARDINAL
admet-1622	246	2	five	CARDINAL
admet-1622	247	1	raje et al	PERSON
admet-1622	248	1	67	CARDINAL
admet-1622	248	2	3d	CARDINAL
admet-1622	248	3	poly(2-ethyl-tetra-oxazoline	PERSON
admet-1622	249	1	two	CARDINAL
admet-1622	251	1	one	CARDINAL
admet-1622	251	2	five	CARDINAL
admet-1622	251	3	80 %	PERCENT
admet-1622	251	4	60 %	PERCENT
admet-1622	251	5	1	CARDINAL
admet-1622	251	6	2	CARDINAL
admet-1622	251	7	80 %	PERCENT
admet-1622	251	8	one	CARDINAL
admet-1622	252	1	3d	CARDINAL
admet-1622	252	2	melocchi et al	ORG
admet-1622	253	1	68	CARDINAL
admet-1622	253	2	years	DATE
admet-1622	254	1	3d	CARDINAL
admet-1622	254	2	one	CARDINAL
admet-1622	257	1	3d	CARDINAL
admet-1622	257	2	20,21	CARDINAL
admet-1622	257	3	kollidon®	ORG
admet-1622	257	4	va64	PRODUCT
admet-1622	258	1	4	CARDINAL
admet-1622	258	2	69	CARDINAL
admet-1622	261	1	b→c	ORG
admet-1622	263	1	4-ii	QUANTITY
admet-1622	264	1	singh	GPE
admet-1622	265	1	70	CARDINAL
admet-1622	265	2	1 µg/ml	QUANTITY
admet-1622	265	3	300 mg/ml	QUANTITY
admet-1622	265	4	11(1	CARDINAL
admet-1622	265	5	2023	CARDINAL
admet-1622	265	6	33	CARDINAL
admet-1622	265	7	3d	CARDINAL
admet-1622	265	8	45	CARDINAL
admet-1622	266	1	parikh et al	PERSON
admet-1622	267	1	74	CARDINAL
admet-1622	269	1	3d	CARDINAL
admet-1622	269	2	2	CARDINAL
admet-1622	270	1	3d	CARDINAL
admet-1622	271	1	4	CARDINAL
admet-1622	271	2	2	CARDINAL
admet-1622	272	1	3d	CARDINAL
admet-1622	272	2	3d	CARDINAL
admet-1622	274	1	3d	CARDINAL
admet-1622	275	1	two	CARDINAL
admet-1622	275	2	3d	CARDINAL
admet-1622	276	1	https://doi.org/10.5599/admet.1622 abu	PERSON
admet-1622	276	2	serajuddin admet &	ORG
admet-1622	276	3	11(1	CARDINAL
admet-1622	276	4	2023	CARDINAL
admet-1622	276	5	33	CARDINAL
admet-1622	276	6	1	CARDINAL
admet-1622	276	7	3d	CARDINAL
admet-1622	276	8	3d	CARDINAL
admet-1622	279	1	3d	CARDINAL
admet-1622	281	1	solanki et al	PERSON
admet-1622	282	1	19	CARDINAL
admet-1622	282	2	3d	CARDINAL
admet-1622	283	1	aho et al	PERSON
admet-1622	284	1	75	CARDINAL
admet-1622	284	2	3d	CARDINAL
admet-1622	285	1	solanki et al	PERSON
admet-1622	285	2	19	CARDINAL
admet-1622	285	3	5	CARDINAL
admet-1622	285	4	1	CARDINAL
admet-1622	285	5	2	CARDINAL
admet-1622	285	6	3	CARDINAL
admet-1622	285	7	2	CARDINAL
admet-1622	285	8	4	CARDINAL
admet-1622	285	9	3	CARDINAL
admet-1622	286	1	5	CARDINAL
admet-1622	286	2	3d	CARDINAL
admet-1622	287	1	5	CARDINAL
admet-1622	287	2	3d	CARDINAL
admet-1622	288	1	11(1	CARDINAL
admet-1622	288	2	2023	CARDINAL
admet-1622	288	3	33	CARDINAL
admet-1622	288	4	3d	CARDINAL
admet-1622	288	5	47	CARDINAL
admet-1622	289	1	19	CARDINAL
admet-1622	289	2	four	CARDINAL
admet-1622	289	3	kollidon va64	PERSON
admet-1622	289	4	aquoat as-mg	PERSON
admet-1622	289	5	3d	CARDINAL
admet-1622	289	6	1-4 mg/ml	QUANTITY
admet-1622	289	7	2	CARDINAL
admet-1622	290	1	1	CARDINAL
admet-1622	290	2	four	CARDINAL
admet-1622	290	3	150 °	QUANTITY
admet-1622	291	1	2	CARDINAL
admet-1622	291	2	at ph 2	CARDINAL
admet-1622	291	3	6.8	CARDINAL
admet-1622	292	1	va64	PRODUCT
admet-1622	293	1	1:1	CARDINAL
admet-1622	293	2	kollidon®	ORG
admet-1622	293	3	va64	PRODUCT
admet-1622	293	4	2	CARDINAL
admet-1622	294	1	kollidon®	ORG
admet-1622	294	2	va64	PRODUCT
admet-1622	294	3	1:1	CARDINAL
admet-1622	294	4	kollidon®	ORG
admet-1622	294	5	va64	PRODUCT
admet-1622	295	1	1:1	CARDINAL
admet-1622	295	2	kollidon®	ORG
admet-1622	295	3	va64	PERSON
admet-1622	295	4	hpmcas mg	FAC
admet-1622	296	1	2	CARDINAL
admet-1622	296	2	1:1	CARDINAL
admet-1622	296	3	va64	PRODUCT
admet-1622	297	1	kollidon va64	PERSON
admet-1622	297	2	3	CARDINAL
admet-1622	297	3	parikh et al	PERSON
admet-1622	298	1	32	CARDINAL
admet-1622	299	1	20 %	PERCENT
admet-1622	299	2	kollidon va64	GPE
admet-1622	299	3	10 %	PERCENT
admet-1622	299	4	15 %	PERCENT
admet-1622	299	5	kollidon	GPE
admet-1622	300	1	3d	CARDINAL
admet-1622	300	2	10 %	PERCENT
admet-1622	300	3	45 %	PERCENT
admet-1622	301	1	va64	PRODUCT
admet-1622	301	2	45 %	PERCENT
admet-1622	302	1	1	CARDINAL
admet-1622	303	1	10 %	PERCENT
admet-1622	303	2	6.8	CARDINAL
admet-1622	304	1	10 %	PERCENT
admet-1622	304	2	+ 90 %	PERCENT
admet-1622	304	3	kollidon va 64	FAC
admet-1622	304	4	10 %	PERCENT
admet-1622	304	5	+ 90 %	PERCENT
admet-1622	304	6	ir printable	PERSON
admet-1622	304	7	10 %	PERCENT
admet-1622	304	8	+ 90 %	PERCENT
admet-1622	304	9	15	CARDINAL
admet-1622	304	10	10 %	PERCENT
admet-1622	304	11	+ 45 %	PERCENT
admet-1622	305	1	+ 45 %	PERCENT
admet-1622	305	2	kollidon va 64	ORG
admet-1622	305	3	10 %	PERCENT
admet-1622	305	4	+ 45 %	PERCENT
admet-1622	305	5	kollidon va 64 + 45 %	ORG
admet-1622	305	6	15	CARDINAL
admet-1622	305	7	210⁰c	DATE
admet-1622	305	8	4	CARDINAL
admet-1622	306	1	two	CARDINAL
admet-1622	306	2	100 % and 60 %	PERCENT
admet-1622	307	1	6	CARDINAL
admet-1622	307	2	3d	CARDINAL
admet-1622	307	3	5	CARDINAL
admet-1622	307	4	60 %	PERCENT
admet-1622	307	5	45	CARDINAL
admet-1622	307	6	120 min	QUANTITY
admet-1622	307	7	1.2	CARDINAL
admet-1622	307	8	6.8	CARDINAL
admet-1622	308	1	100 %	PERCENT
admet-1622	308	2	over 80 %	PERCENT
admet-1622	308	3	1.2	CARDINAL
admet-1622	308	4	6.8	CARDINAL
admet-1622	308	5	2	CARDINAL
admet-1622	308	6	3	CARDINAL
admet-1622	309	1	solanki et al	PERSON
admet-1622	310	1	19	CARDINAL
admet-1622	310	2	fda	ORG
admet-1622	310	3	85 %	PERCENT
admet-1622	310	4	60 min	DATE
admet-1622	310	5	76	CARDINAL
admet-1622	310	6	2-3	DATE
admet-1622	310	7	77	CARDINAL
admet-1622	311	1	3d	CARDINAL
admet-1622	312	1	3d	CARDINAL
admet-1622	312	2	https://doi.org/10.5599/admet.1622 abu	GPE
admet-1622	313	1	serajuddin admet &	ORG
admet-1622	313	2	11(1	CARDINAL
admet-1622	313	3	2023	CARDINAL
admet-1622	313	4	33	CARDINAL
admet-1622	313	5	55 48	CARDINAL
admet-1622	314	1	1:1 w	MONEY
admet-1622	314	2	w	CARDINAL
admet-1622	314	3	va64	PRODUCT
admet-1622	314	4	15cp	DATE
admet-1622	314	5	3:1	CARDINAL
admet-1622	315	1	6	CARDINAL
admet-1622	316	1	3d	CARDINAL
admet-1622	316	2	10 %	PERCENT
admet-1622	316	3	1:1	CARDINAL
admet-1622	316	4	kollidon	ORG
admet-1622	316	5	va64-affinisol	PERSON
admet-1622	316	6	15	CARDINAL
admet-1622	316	7	100 % and 60 %	PERCENT
admet-1622	316	8	2	CARDINAL
admet-1622	316	9	6.8	CARDINAL
admet-1622	317	1	5	CARDINAL
admet-1622	317	2	3d	CARDINAL
admet-1622	318	1	150 °	QUANTITY
admet-1622	318	2	210 °	QUANTITY
admet-1622	318	3	3d	CARDINAL
admet-1622	322	1	2	CARDINAL
admet-1622	322	2	3d	CARDINAL
admet-1622	322	3	3d	CARDINAL
admet-1622	322	4	two	CARDINAL
admet-1622	322	5	3d	CARDINAL
admet-1622	324	1	3d	CARDINAL
admet-1622	324	2	7	CARDINAL
admet-1622	324	3	20	CARDINAL
admet-1622	325	1	kollidon®	ORG
admet-1622	325	2	va64	PERSON
admet-1622	326	1	300 mg/ml	QUANTITY
admet-1622	327	1	150 °	QUANTITY
admet-1622	327	2	115 °	QUANTITY
admet-1622	328	1	va64	PRODUCT
admet-1622	328	2	as low as	CARDINAL
admet-1622	328	3	120 °	QUANTITY
admet-1622	330	1	50 %	PERCENT
admet-1622	330	2	11(1	CARDINAL
admet-1622	330	3	2023	CARDINAL
admet-1622	330	4	33	CARDINAL
admet-1622	330	5	3d	CARDINAL
admet-1622	330	6	https://doi.org/10.5599/admet.1622 49	DATE
admet-1622	330	7	7	CARDINAL
admet-1622	330	8	3d	CARDINAL
admet-1622	333	1	6.8	CARDINAL
admet-1622	333	2	30 min	DATE
admet-1622	334	1	8	CARDINAL
admet-1622	335	1	3d	CARDINAL
admet-1622	335	2	15 %	PERCENT
admet-1622	335	3	1:2	CARDINAL
admet-1622	335	4	100 % and 60 %	PERCENT
admet-1622	335	5	2	CARDINAL
admet-1622	335	6	6.8	CARDINAL
admet-1622	336	1	kol, hal	ORG
admet-1622	336	2	ga	ORG
admet-1622	336	3	kollidon®	PERSON
admet-1622	336	4	va64	PRODUCT
admet-1622	337	1	3d	CARDINAL
admet-1622	337	2	21	CARDINAL
admet-1622	337	3	kollidon	ORG
admet-1622	337	4	va64-haloperidol-	PERSON
admet-1622	337	5	120 °	QUANTITY
admet-1622	337	6	125 and 100 °	QUANTITY
admet-1622	337	7	15 % and 30 %	PERCENT
admet-1622	338	1	as high as 50 %	PERCENT
admet-1622	338	2	40 and 50 %	PERCENT
admet-1622	338	3	only 15	CARDINAL
admet-1622	338	4	30 %	PERCENT
admet-1622	339	1	80 %	PERCENT
admet-1622	339	2	100%	PERCENT
admet-1622	339	3	30 min	QUANTITY
admet-1622	339	4	1.2	CARDINAL
admet-1622	339	5	6.8	CARDINAL
admet-1622	340	1	https://doi.org/10.5599/admet.1622 abu	PERSON
admet-1622	340	2	serajuddin admet &	ORG
admet-1622	340	3	11(1	CARDINAL
admet-1622	340	4	2023	CARDINAL
admet-1622	340	5	33	CARDINAL
admet-1622	340	6	recent years	DATE
admet-1622	340	7	3d	CARDINAL
admet-1622	340	8	3d	CARDINAL
admet-1622	342	1	3d	CARDINAL
admet-1622	344	1	pvps	ORG
admet-1622	344	2	kollidon®	ORG
admet-1622	344	3	va64	PRODUCT
admet-1622	344	4	3d	CARDINAL
admet-1622	346	1	kollidon®	ORG
admet-1622	346	2	va64	PRODUCT
admet-1622	346	3	celluloses	PERSON
admet-1622	348	1	~50	ORG
admet-1622	354	1	two	CARDINAL
admet-1622	354	2	3d	CARDINAL
admet-1622	355	1	3d	CARDINAL
admet-1622	356	1	3d	CARDINAL
admet-1622	359	1	1	CARDINAL
admet-1622	359	2	a. awad	PERSON
admet-1622	359	3	a. goyanes	PERSON
admet-1622	359	4	a. basit	PERSON
admet-1622	359	5	a. zidan	PERSON
admet-1622	359	6	c. xu	PERSON
admet-1622	359	7	d. li	PERSON
admet-1622	359	8	r. narayan	PERSON
admet-1622	359	9	r.k. chen	PERSON
admet-1622	361	1	145	CARDINAL
admet-1622	361	2	2023	CARDINAL
admet-1622	363	1	2	CARDINAL
admet-1622	363	2	wong	GPE
admet-1622	363	3	a. hernandez	PERSON
admet-1622	365	1	2012	DATE
admet-1622	365	2	2012) 208760	DATE
admet-1622	367	1	11(1	CARDINAL
admet-1622	367	2	2023	CARDINAL
admet-1622	367	3	33	CARDINAL
admet-1622	367	4	3d	CARDINAL
admet-1622	367	5	3	CARDINAL
admet-1622	367	6	fda	ORG
admet-1622	368	1	november 12	DATE
admet-1622	368	2	2022	CARDINAL
admet-1622	369	1	4	CARDINAL
admet-1622	369	2	a. melocchi	PERSON
admet-1622	369	3	m. uboldi	PERSON
admet-1622	369	4	m. cerea	PERSON
admet-1622	369	5	a. foppoli	PERSON
admet-1622	369	6	a. maroni	PERSON
admet-1622	369	7	s. moutaharrik	PERSON
admet-1622	369	8	l. palugan	PERSON
admet-1622	369	9	l. zema	PERSON
admet-1622	369	10	a. gazzaniga	PERSON
admet-1622	370	1	3d	CARDINAL
admet-1622	371	1	2020	DATE
admet-1622	371	2	2943	CARDINAL
admet-1622	372	1	5	CARDINAL
admet-1622	372	2	j. wang	PERSON
admet-1622	372	3	y. zhang	PERSON
admet-1622	372	4	n.h.	GPE
admet-1622	372	5	pillai	GPE
admet-1622	372	6	r. thakkar	PERSON
admet-1622	372	7	a. nokhodchi	PERSON
admet-1622	372	8	m. maniruzzaman	PERSON
admet-1622	373	1	3d	CARDINAL
admet-1622	374	1	174	CARDINAL
admet-1622	374	2	2021	CARDINAL
admet-1622	374	3	294	CARDINAL
admet-1622	376	1	6	CARDINAL
admet-1622	376	2	w. jamróz	PERSON
admet-1622	376	3	j. szafraniec	PERSON
admet-1622	376	4	m. kurek	PERSON
admet-1622	376	5	r. jachowicz	PERSON
admet-1622	377	1	3d	CARDINAL
admet-1622	378	1	35(9	CARDINAL
admet-1622	378	2	2018	DATE
admet-1622	378	3	1	CARDINAL
admet-1622	380	1	c. parulski	PERSON
admet-1622	380	2	o. jennotte	ORG
admet-1622	380	3	a. lechanteur	PERSON
admet-1622	380	4	b. evrard	PERSON
admet-1622	381	1	3d	CARDINAL
admet-1622	383	1	175	CARDINAL
admet-1622	383	2	2021	CARDINAL
admet-1622	383	3	113810	DATE
admet-1622	384	1	8	CARDINAL
admet-1622	384	2	h. ragelle	PERSON
admet-1622	384	3	s. rahimian	PERSON
admet-1622	384	4	e.a.	GPE
admet-1622	384	5	p.d. westenskow	PERSON
admet-1622	384	6	m.w.	GPE
admet-1622	384	7	g. schwach	PERSON
admet-1622	384	8	r. langer	PERSON
admet-1622	386	1	178	CARDINAL
admet-1622	386	2	2021) 113990	DATE
admet-1622	388	1	9	CARDINAL
admet-1622	388	2	reddy	PERSON
admet-1622	390	1	international journal of pharmaceutics 589 (2020) 119820	ORG
admet-1622	391	1	10	CARDINAL
admet-1622	391	2	i. seoane-viaño	PERSON
admet-1622	391	3	trenfield	PERSON
admet-1622	391	4	a.w. basit	PERSON
admet-1622	391	5	a. goyanes	PERSON
admet-1622	392	1	3d	CARDINAL
admet-1622	393	1	174	CARDINAL
admet-1622	393	2	2021	CARDINAL
admet-1622	393	3	553	CARDINAL
admet-1622	394	1	11	CARDINAL
admet-1622	394	2	trenfield	PERSON
admet-1622	394	3	a. awad	PERSON
admet-1622	394	4	a. goyanes	PERSON
admet-1622	394	5	s. gaisford	PERSON
admet-1622	394	6	a.w. basit	PERSON
admet-1622	395	1	3d	CARDINAL
admet-1622	396	1	39(5	PRODUCT
admet-1622	396	2	2018	DATE
admet-1622	396	3	440	CARDINAL
admet-1622	397	1	12	CARDINAL
admet-1622	397	2	l. zema	PERSON
admet-1622	397	3	a. melocchi	PERSON
admet-1622	397	4	a. maroni	PERSON
admet-1622	397	5	a. gazzaniga	PERSON
admet-1622	398	1	three	CARDINAL
admet-1622	399	1	2017	CARDINAL
admet-1622	399	2	1697-1705	DATE
admet-1622	400	1	13	CARDINAL
admet-1622	400	2	s. bandari	PERSON
admet-1622	400	3	d. nyavanandi	PERSON
admet-1622	400	4	n. dumpa	PERSON
admet-1622	400	5	m.a.	PERSON
admet-1622	400	6	repka	PERSON
admet-1622	402	1	172	CARDINAL
admet-1622	402	2	2021	CARDINAL
admet-1622	402	3	52-63	DATE
admet-1622	403	1	14	CARDINAL
admet-1622	403	2	d.k. tan	GPE
admet-1622	403	3	m. maniruzzaman	PERSON
admet-1622	403	4	a. nokhodchi	PERSON
admet-1622	404	1	3d	CARDINAL
admet-1622	405	1	10(4	CARDINAL
admet-1622	405	2	2018	DATE
admet-1622	405	3	203	CARDINAL
admet-1622	406	1	15	CARDINAL
admet-1622	406	2	j.c. burley	PERSON
admet-1622	406	3	m.r. alexander	ORG
admet-1622	406	4	j. yang	PERSON
admet-1622	406	5	c.j. roberts	PERSON
admet-1622	407	1	3d	CARDINAL
admet-1622	407	2	five	CARDINAL
admet-1622	408	1	217	CARDINAL
admet-1622	408	2	2015	CARDINAL
admet-1622	408	3	308	CARDINAL
admet-1622	409	1	16	CARDINAL
admet-1622	409	2	s.a. khaled	PERSON
admet-1622	409	3	j.c. burley	PERSON
admet-1622	409	4	m.r. alexander	ORG
admet-1622	409	5	j. yang	PERSON
admet-1622	409	6	c.j. roberts	PERSON
admet-1622	410	1	3d	CARDINAL
admet-1622	411	1	international journal of pharmaceutics 494(2	ORG
admet-1622	411	2	2015	CARDINAL
admet-1622	411	3	643	CARDINAL
admet-1622	412	1	17	CARDINAL
admet-1622	412	2	p.a. dickinson	GPE
admet-1622	412	3	f. kesisoglou	PERSON
admet-1622	412	4	t. flanagan	PERSON
admet-1622	412	5	m.n. martinez	GPE
admet-1622	412	6	h.b. mistry	PERSON
admet-1622	412	7	j.r. crison	PERSON
admet-1622	412	8	j.e. polli	PERSON
admet-1622	412	9	m.t. cruañes	GPE
admet-1622	412	10	a.t. serajuddin	PERSON
admet-1622	412	11	a. müllertz	PERSON
admet-1622	413	1	biopharmaceutics	ORG
admet-1622	414	1	105	CARDINAL
admet-1622	414	2	2016	CARDINAL
admet-1622	415	1	18	CARDINAL
admet-1622	415	2	a. selen	PERSON
admet-1622	415	3	p.a. dickinson	GPE
admet-1622	415	4	a. müllertz	PERSON
admet-1622	415	5	j.r. crison	PERSON
admet-1622	415	6	h.b. mistry	PERSON
admet-1622	415	7	m.t. cruañes	GPE
admet-1622	415	8	m.n. martinez	GPE
admet-1622	415	9	h. lennernäs	PERSON
admet-1622	415	10	t.l. wigal	GPE
admet-1622	415	11	d.c	GPE
admet-1622	416	1	biopharmaceutics	ORG
admet-1622	417	1	103	CARDINAL
admet-1622	417	2	2014	DATE
admet-1622	417	3	3377-3397	CARDINAL
admet-1622	419	1	serajuddin admet &	ORG
admet-1622	419	2	11(1	CARDINAL
admet-1622	419	3	2023	CARDINAL
admet-1622	419	4	33	CARDINAL
admet-1622	419	5	19	CARDINAL
admet-1622	419	6	solanki	PERSON
admet-1622	419	7	m. tahsin	PERSON
admet-1622	419	8	a.v. shah	PERSON
admet-1622	419	9	a.t. serajuddin	PERSON
admet-1622	420	1	3d	CARDINAL
admet-1622	421	1	107	CARDINAL
admet-1622	421	2	2018	DATE
admet-1622	421	3	390	CARDINAL
admet-1622	422	1	20	CARDINAL
admet-1622	422	2	patel	PERSON
admet-1622	422	3	a.t.	PERSON
admet-1622	422	4	serajuddin	GPE
admet-1622	423	1	3d	CARDINAL
admet-1622	424	1	international journal of pharmaceutics	ORG
admet-1622	424	2	600	CARDINAL
admet-1622	424	3	2021	CARDINAL
admet-1622	424	4	120524	DATE
admet-1622	425	1	https://doi.org/10.1016/j.ijpharm.2021.120524	ORG
admet-1622	425	2	21	CARDINAL
admet-1622	425	3	patel	PERSON
admet-1622	425	4	a.t. serajuddin	PERSON
admet-1622	426	1	3d	CARDINAL
admet-1622	427	1	international journal of pharmaceutics	ORG
admet-1622	427	2	2023	CARDINAL
admet-1622	428	1	22	CARDINAL
admet-1622	428	2	k. ilyés	PERSON
admet-1622	428	3	n.k. kovács	PERSON
admet-1622	428	4	a. balogh	PERSON
admet-1622	428	5	e. borbás	PERSON
admet-1622	428	6	b. farkas	PERSON
admet-1622	428	7	t. casian	GPE
admet-1622	428	8	g. marosi	PERSON
admet-1622	428	9	i. tomuță	PERSON
admet-1622	428	10	z.k. nagy	GPE
admet-1622	429	1	3d	CARDINAL
admet-1622	430	1	european journal of pharmaceutical sciences	ORG
admet-1622	430	2	129	CARDINAL
admet-1622	430	3	2019) 110123	DATE
admet-1622	432	1	23	CARDINAL
admet-1622	432	2	r. govender	PERSON
admet-1622	432	3	e.o. kissi	PERSON
admet-1622	432	4	a. larsson	PERSON
admet-1622	432	5	i. tho	PERSON
admet-1622	433	1	177	CARDINAL
admet-1622	433	2	2021) 113923	DATE
admet-1622	434	1	24	CARDINAL
admet-1622	434	2	j.m. nasereddin	GPE
admet-1622	434	3	n. wellner	PERSON
admet-1622	434	4	m. alhijjaj	PERSON
admet-1622	434	5	p. belton	PERSON
admet-1622	434	6	s. qi.	PERSON
admet-1622	434	7	3d	CARDINAL
admet-1622	435	1	35	CARDINAL
admet-1622	435	2	2018	DATE
admet-1622	435	3	1	CARDINAL
admet-1622	437	1	25	CARDINAL
admet-1622	437	2	s. borandeh	PERSON
admet-1622	437	3	b. van bochove	PERSON
admet-1622	437	4	a. teotia	PERSON
admet-1622	437	5	j. seppälä	PERSON
admet-1622	439	1	173	CARDINAL
admet-1622	439	2	2021	CARDINAL
admet-1622	439	3	349	CARDINAL
admet-1622	441	1	26	CARDINAL
admet-1622	441	2	s. cailleaux	PERSON
admet-1622	441	3	sanchez	PERSON
admet-1622	441	4	y.a. gueche	GPE
admet-1622	441	5	b. bataille	PERSON
admet-1622	441	6	i. soulairol	PERSON
admet-1622	443	1	330	CARDINAL
admet-1622	443	2	2021	CARDINAL
admet-1622	443	3	821	CARDINAL
admet-1622	445	1	27	CARDINAL
admet-1622	445	2	s. henry	PERSON
admet-1622	445	3	a. samaro	PERSON
admet-1622	445	4	b. shaqour	PERSON
admet-1622	445	5	j. macedo	PERSON
admet-1622	445	6	v. vanhoorne	PERSON
admet-1622	446	1	3d	CARDINAL
admet-1622	447	1	international journal of pharmaceutics	ORG
admet-1622	447	2	598	CARDINAL
admet-1622	447	3	2021	CARDINAL
admet-1622	448	1	28	CARDINAL
admet-1622	448	2	r. liu	PERSON
admet-1622	448	3	3rd	ORDINAL
admet-1622	448	4	boca raton	GPE
admet-1622	448	5	2018	DATE
admet-1622	449	1	https:/doi.org/10.1201/9781315120492	CARDINAL
admet-1622	450	1	29	CARDINAL
admet-1622	450	2	pereira	GPE
admet-1622	450	3	s. figueiredo	PERSON
admet-1622	450	4	a.i. fernandes	PERSON
admet-1622	450	5	j.f	GPE
admet-1622	451	1	12	CARDINAL
admet-1622	451	2	2020	DATE
admet-1622	451	3	795	CARDINAL
admet-1622	453	1	30	CARDINAL
admet-1622	453	2	g.m. khalid	PERSON
admet-1622	453	3	n. billa	PERSON
admet-1622	454	1	3d	CARDINAL
admet-1622	455	1	14	CARDINAL
admet-1622	455	2	2022	CARDINAL
admet-1622	455	3	690	CARDINAL
admet-1622	456	1	31	CARDINAL
admet-1622	456	2	pinho	GPE
admet-1622	456	3	a.l.	GPE
admet-1622	456	4	lima	GPE
admet-1622	456	5	l.l. sa-barreto	ORG
admet-1622	456	6	t. gratieri	PERSON
admet-1622	456	7	g.m.	PERSON
admet-1622	457	1	gelfuso	PERSON
admet-1622	457	2	r.n.	GPE
admet-1622	457	3	m. cunha-filho	PERSON
admet-1622	458	1	3d	CARDINAL
admet-1622	459	1	22	CARDINAL
admet-1622	459	2	2021	CARDINAL
admet-1622	459	3	1-12	CARDINAL
admet-1622	460	1	32	CARDINAL
admet-1622	460	2	t. parikh	PERSON
admet-1622	460	3	s.s. gupta	PERSON
admet-1622	460	4	a.k. meena	ORG
admet-1622	460	5	i. vitez	PERSON
admet-1622	460	6	n. mahajan	PERSON
admet-1622	460	7	a.t. serajuddin	PERSON
admet-1622	462	1	104	CARDINAL
admet-1622	463	1	33	CARDINAL
admet-1622	463	2	c. wei	PERSON
admet-1622	463	3	n.g. solanki	ORG
admet-1622	463	4	j.m. vasoya	GPE
admet-1622	463	5	a.v. shah	PERSON
admet-1622	463	6	a.t. serajuddin	PERSON
admet-1622	464	1	3d	CARDINAL
admet-1622	465	1	journal of pharmaceutical sciences 109 (	ORG
admet-1622	465	2	2020	DATE
admet-1622	465	3	1558-1572	CARDINAL
admet-1622	466	1	34	CARDINAL
admet-1622	466	2	n. solanki	PERSON
admet-1622	466	3	s.s. gupta	PERSON
admet-1622	466	4	a.t. serajuddin	PERSON
admet-1622	468	1	https://doi.org/10.1016/j.ijpharm.2021.120524 https://doi.org/10.1016/j.ijpharm.2021.120524	PERSON
admet-1622	469	1	11(1	CARDINAL
admet-1622	469	2	2023	CARDINAL
admet-1622	469	3	33	CARDINAL
admet-1622	469	4	3d	CARDINAL
admet-1622	469	5	https://doi.org/10.5599/admet.1622 53 european journal of pharmaceutical sciences	ORG
admet-1622	469	6	111	CARDINAL
admet-1622	469	7	2018	DATE
admet-1622	469	8	482	CARDINAL
admet-1622	470	1	35	CARDINAL
admet-1622	470	2	s.s. gupta	PERSON
admet-1622	470	3	t. parikh	PERSON
admet-1622	470	4	a.k. meena	ORG
admet-1622	470	5	n. mahajan	PERSON
admet-1622	470	6	i. vitez	PERSON
admet-1622	470	7	a.t. serajuddin	PERSON
admet-1622	471	1	®	ORG
admet-1622	472	1	international journal of pharmaceutics	ORG
admet-1622	472	2	478	CARDINAL
admet-1622	472	3	2015	CARDINAL
admet-1622	472	4	232	CARDINAL
admet-1622	473	1	36	CARDINAL
admet-1622	473	2	n.l.	GPE
admet-1622	473	3	s. fantaus	PERSON
admet-1622	473	4	beck	PERSON
admet-1622	474	1	3d	CARDINAL
admet-1622	475	1	international journal of pharmaceutics	ORG
admet-1622	475	2	2022	CARDINAL
admet-1622	476	1	https://doi.org/10.1016/j.ijpharm.2022.122066	PERSON
admet-1622	477	1	37	CARDINAL
admet-1622	479	1	opin	PERSON
admet-1622	479	2	10	CARDINAL
admet-1622	479	3	131	CARDINAL
admet-1622	481	1	38	CARDINAL
admet-1622	481	2	s. tort	PERSON
admet-1622	481	3	f. acartürk	PERSON
admet-1622	482	1	3d	CARDINAL
admet-1622	483	1	36	CARDINAL
admet-1622	483	2	2019	CARDINAL
admet-1622	483	3	1-13	DATE
admet-1622	485	1	39	CARDINAL
admet-1622	485	2	k. pietrzak	PERSON
admet-1622	485	3	a. isreb	PERSON
admet-1622	485	4	m.a.	PERSON
admet-1622	485	5	alhnan	GPE
admet-1622	486	1	3d	CARDINAL
admet-1622	487	1	european journal of pharmaceutics	ORG
admet-1622	487	2	96	CARDINAL
admet-1622	487	3	2015	CARDINAL
admet-1622	487	4	380	CARDINAL
admet-1622	489	1	y.m.	GPE
admet-1622	490	1	3d	CARDINAL
admet-1622	491	1	international journal of pharmaceutics	ORG
admet-1622	491	2	599	CARDINAL
admet-1622	491	3	2021) 120402	DATE
admet-1622	493	1	41	CARDINAL
admet-1622	493	2	x. lin	PERSON
admet-1622	493	3	l. su	PERSON
admet-1622	493	4	n. li	PERSON
admet-1622	493	5	y. hu	PERSON
admet-1622	493	6	g. tang	PERSON
admet-1622	493	7	l. liu	PERSON
admet-1622	493	8	h. li	PERSON
admet-1622	493	9	z. yang	PERSON
admet-1622	494	1	journal of drug delivery science	ORG
admet-1622	494	2	48	DATE
admet-1622	494	3	2018	DATE
admet-1622	494	4	328	CARDINAL
admet-1622	496	1	42	CARDINAL
admet-1622	496	2	h. liu	PERSON
admet-1622	496	3	p. wang	PERSON
admet-1622	496	4	x. zhang	PERSON
admet-1622	496	5	f. shen	PERSON
admet-1622	496	6	c.g. gogos	PERSON
admet-1622	498	1	international journal of pharmaceutics	ORG
admet-1622	498	2	383	CARDINAL
admet-1622	498	3	2010	DATE
admet-1622	498	4	161	CARDINAL
admet-1622	499	1	https://doi.org/10.1016/j.ijpharm.2009.09.003	CARDINAL
admet-1622	499	2	43	CARDINAL
admet-1622	499	3	m. alhijjaj	PERSON
admet-1622	499	4	p. belton	PERSON
admet-1622	499	5	s. qi	PERSON
admet-1622	500	1	3d	CARDINAL
admet-1622	501	1	european journal of pharmaceutics	ORG
admet-1622	501	2	108	CARDINAL
admet-1622	501	3	2016) 111125	DATE
admet-1622	502	1	44	CARDINAL
admet-1622	502	2	x. wang	PERSON
admet-1622	502	3	y. zhu	PERSON
admet-1622	502	4	x. zhao	PERSON
admet-1622	502	5	s. zhang	PERSON
admet-1622	502	6	m. cao	PERSON
admet-1622	502	7	x. wang	PERSON
admet-1622	502	8	w. li	PERSON
admet-1622	502	9	e100	ORG
admet-1622	503	1	2022	CARDINAL
admet-1622	503	2	1	CARDINAL
admet-1622	504	1	45	CARDINAL
admet-1622	504	2	n. washington	PERSON
admet-1622	504	3	c. washington	GPE
admet-1622	504	4	c. wilson	PERSON
admet-1622	504	5	crc press	ORG
admet-1622	504	6	2000	DATE
admet-1622	504	7	0429204590	DATE
admet-1622	505	1	46	CARDINAL
admet-1622	505	2	y. yang	PERSON
admet-1622	505	3	h. wang	PERSON
admet-1622	505	4	x. xu	PERSON
admet-1622	505	5	g. yang	PERSON
admet-1622	507	1	international journal of pharmaceutics	ORG
admet-1622	507	2	599	CARDINAL
admet-1622	507	3	2021	CARDINAL
admet-1622	507	4	120410	DATE
admet-1622	508	1	47	CARDINAL
admet-1622	508	2	m. saydam	PERSON
admet-1622	508	3	s. takka	PERSON
admet-1622	509	1	3	CARDINAL
admet-1622	510	1	european journal of pharmaceutical sciences	ORG
admet-1622	510	2	152	CARDINAL
admet-1622	510	3	2020) 105426	DATE
admet-1622	512	1	48	CARDINAL
admet-1622	512	2	d. stefaniak	PERSON
admet-1622	512	3	b. arafat	PERSON
admet-1622	512	4	a. isreb	PERSON
admet-1622	513	1	wan	PERSON
admet-1622	513	2	m.a	PERSON
admet-1622	513	3	alhnan	GPE
admet-1622	514	1	3d	CARDINAL
admet-1622	515	1	33	CARDINAL
admet-1622	515	2	2016	CARDINAL
admet-1622	515	3	2704	CARDINAL
admet-1622	517	1	49	CARDINAL
admet-1622	517	2	m. sadia	PERSON
admet-1622	517	3	a. sośnicka	PERSON
admet-1622	517	4	b. arafat	PERSON
admet-1622	517	5	a. isreb	PERSON
admet-1622	517	6	w. ahmed	PERSON
admet-1622	517	7	a. kelarakis	PERSON
admet-1622	517	8	alhnan.	GPE
admet-1622	518	1	3d	CARDINAL
admet-1622	519	1	international journal of pharmaceutics	ORG
admet-1622	519	2	513	CARDINAL
admet-1622	519	3	2016	CARDINAL
admet-1622	519	4	659	CARDINAL
admet-1622	521	1	50	CARDINAL
admet-1622	521	2	m. bitar	PERSON
admet-1622	521	3	s. gold,	PERSON
admet-1622	521	4	a. sobczuk	PERSON
admet-1622	521	5	s. hirsch	PERSON
admet-1622	521	6	j. ogorka	PERSON
admet-1622	521	7	g. imanidis	PERSON
admet-1622	522	1	3d	CARDINAL
admet-1622	523	1	https://doi.org/10.1016/j.ijpharm.2021.120410 https://doi.org/10.1016/j.ejps.2020.105426	PERSON
admet-1622	524	1	abu t.m	PERSON
admet-1622	525	1	serajuddin admet &	ORG
admet-1622	525	2	11(1	CARDINAL
admet-1622	525	3	2023	CARDINAL
admet-1622	525	4	33	CARDINAL
admet-1622	525	5	55 54	CARDINAL
admet-1622	526	1	international journal of pharmaceutics	ORG
admet-1622	526	2	599	CARDINAL
admet-1622	526	3	2021) 120417	DATE
admet-1622	527	1	51	CARDINAL
admet-1622	527	2	s. tort	PERSON
admet-1622	527	3	f. acartürk	PERSON
admet-1622	528	1	three	CARDINAL
admet-1622	529	1	journal of drug delivery science	ORG
admet-1622	529	2	74	CARDINAL
admet-1622	529	3	2022	CARDINAL
admet-1622	529	4	103538	DATE
admet-1622	530	1	52	CARDINAL
admet-1622	530	2	h. öblom	PERSON
admet-1622	530	3	j. zhang	PERSON
admet-1622	530	4	m. pimparade	PERSON
admet-1622	530	5	i. speer	PERSON
admet-1622	530	6	m. preis	PERSON
admet-1622	530	7	m. repka	PERSON
admet-1622	530	8	n. sandler	PERSON
admet-1622	531	1	3d	CARDINAL
admet-1622	532	1	20 (2019	DATE
admet-1622	532	2	1-13	DATE
admet-1622	534	1	53	CARDINAL
admet-1622	534	2	g. kollamaram	PERSON
admet-1622	534	3	d.m. croker	PERSON
admet-1622	534	4	g.m. walker	PERSON
admet-1622	534	5	a. goyanes	PERSON
admet-1622	534	6	a.w. basit	PERSON
admet-1622	534	7	s. gaisford	PERSON
admet-1622	535	1	3d	CARDINAL
admet-1622	536	1	international journal of pharmaceutics	ORG
admet-1622	536	2	545	CARDINAL
admet-1622	536	3	2018	DATE
admet-1622	536	4	144	CARDINAL
admet-1622	538	1	54	CARDINAL
admet-1622	538	2	patel	PERSON
admet-1622	538	3	a.t. serajuddin	PERSON
admet-1622	538	4	i. polyvinylpyrrolidone	PERSON
admet-1622	539	1	international journal of pharmaceutics	ORG
admet-1622	539	2	616	CARDINAL
admet-1622	539	3	2022	CARDINAL
admet-1622	539	4	121532	DATE
admet-1622	540	1	55	CARDINAL
admet-1622	540	2	m. đuranović	PERSON
admet-1622	540	3	m. madžarević	PERSON
admet-1622	540	4	b. ivković	PERSON
admet-1622	540	5	s. ibrić	PERSON
admet-1622	540	6	s. cvijić	PERSON
admet-1622	541	1	3d	CARDINAL
admet-1622	542	1	international journal of pharmaceutics	ORG
admet-1622	542	2	610	CARDINAL
admet-1622	542	3	2021	CARDINAL
admet-1622	542	4	121194	DATE
admet-1622	544	1	56	CARDINAL
admet-1622	544	2	k. shi	PERSON
admet-1622	544	3	j.p.	GPE
admet-1622	544	4	m. maniruzzaman	PERSON
admet-1622	544	5	a. nokhodchi	PERSON
admet-1622	545	1	3d	CARDINAL
admet-1622	546	1	international journal of pharmaceutics	ORG
admet-1622	546	2	597	CARDINAL
admet-1622	546	3	2021	CARDINAL
admet-1622	547	1	57	CARDINAL
admet-1622	547	2	l. krueger	PERSON
admet-1622	547	3	j.a. miles	PERSON
admet-1622	547	4	a. popat	PERSON
admet-1622	548	1	3d	CARDINAL
admet-1622	549	1	351	CARDINAL
admet-1622	549	2	2022	CARDINAL
admet-1622	549	3	444	CARDINAL
admet-1622	551	1	58	CARDINAL
admet-1622	551	2	r. thakkar	PERSON
admet-1622	551	3	j. zhang	PERSON
admet-1622	551	4	y. zhang	PERSON
admet-1622	551	5	v. kulkarni	PERSON
admet-1622	551	6	m. maniruzzaman	PERSON
admet-1622	552	1	3dimensional	CARDINAL
admet-1622	552	2	3-d	QUANTITY
admet-1622	553	1	12	CARDINAL
admet-1622	553	2	2020) 1872	DATE
admet-1622	555	1	59	CARDINAL
admet-1622	555	2	j. zhang	PERSON
admet-1622	555	3	r. thakkar	PERSON
admet-1622	555	4	y. zhang	PERSON
admet-1622	555	5	m. maniruzzaman	PERSON
admet-1622	555	6	3d	CARDINAL
admet-1622	556	1	international journal of pharmaceutics	ORG
admet-1622	556	2	590	CARDINAL
admet-1622	556	3	2020) 119945	DATE
admet-1622	557	1	60	CARDINAL
admet-1622	557	2	a.b.	GPE
admet-1622	557	3	a.w. basit	PERSON
admet-1622	557	4	s. gaisford	PERSON
admet-1622	558	1	3d	CARDINAL
admet-1622	558	2	3dp	ORDINAL
admet-1622	559	1	international journal of pharmaceutics	ORG
admet-1622	559	2	476	CARDINAL
admet-1622	559	3	2014	DATE
admet-1622	559	4	88	CARDINAL
admet-1622	560	1	61	CARDINAL
admet-1622	560	2	b. arafat	PERSON
admet-1622	560	3	m. wojsz, a. isreb	PERSON
admet-1622	560	4	r.t. forbes	PERSON
admet-1622	560	5	m. isreb	PERSON
admet-1622	560	6	w. ahmed	PERSON
admet-1622	560	7	t. arafat	PERSON
admet-1622	560	8	m.a	PERSON
admet-1622	560	9	alhnan	GPE
admet-1622	561	1	3d	CARDINAL
admet-1622	562	1	european journal of pharmaceutical sciences	ORG
admet-1622	562	2	118	CARDINAL
admet-1622	562	3	2018	DATE
admet-1622	562	4	191	CARDINAL
admet-1622	563	1	62	CARDINAL
admet-1622	563	2	m. sadia	PERSON
admet-1622	563	3	b. arafat	PERSON
admet-1622	563	4	w. ahmed	PERSON
admet-1622	563	5	r.t. forbes	PERSON
admet-1622	563	6	m.a	PERSON
admet-1622	563	7	alhnan	GPE
admet-1622	564	1	3d	CARDINAL
admet-1622	565	1	269	CARDINAL
admet-1622	565	2	2018	DATE
admet-1622	565	3	355	CARDINAL
admet-1622	566	1	https://doi.org/10.1016/j.jconrel.2017.11.022	ORG
admet-1622	567	1	63	CARDINAL
admet-1622	567	2	a. isreb	PERSON
admet-1622	567	3	k. baj	PERSON
admet-1622	567	4	m. wojsz	PERSON
admet-1622	567	5	m. isreb	PERSON
admet-1622	567	6	m. peak	PERSON
admet-1622	567	7	m.a.	ORG
admet-1622	567	8	alhnan	PERSON
admet-1622	568	1	3d	CARDINAL
admet-1622	569	1	international journal of pharmaceutics	ORG
admet-1622	569	2	564	CARDINAL
admet-1622	569	3	2019	CARDINAL
admet-1622	569	4	98	CARDINAL
admet-1622	570	1	64	CARDINAL
admet-1622	570	2	s.a. khaled	PERSON
admet-1622	570	3	m.r. alexander	PERSON
admet-1622	570	4	d.j. irvine	PERSON
admet-1622	570	5	r.d. wildman	PERSON
admet-1622	570	6	m.j.	PERSON
admet-1622	570	7	wallace	PERSON
admet-1622	570	8	s. sharpe	PERSON
admet-1622	570	9	j. yoo	PERSON
admet-1622	570	10	c.j. roberts	PERSON
admet-1622	571	1	3d	CARDINAL
admet-1622	572	1	19	DATE
admet-1622	572	2	3403	CARDINAL
admet-1622	573	1	https://doi.org/10.1208/s12249-018-1107-z https://doi.org/10.1016/j.ijpharm.2021.120417	ORG
admet-1622	573	2	https://doi.org/10.1016/j.ijpharm.2022.121532	NORP
admet-1622	573	3	https://doi.org/10.1016/j.ijpharm.2020.119945 https://doi.org/10.1016/j.ijpharm.2014.09.044 https://doi.org/10.1016/j.ijpharm.2014.09.044 https://doi.org/10.1016/j.ejps.2018.03.019 https://doi.org/10.1016/j.jconrel.2017.11.022	PERSON
admet-1622	573	4	https://doi.org/10.1208/s12249-018-1107-z https://doi.org/10.1208/s12249-018-1107-z admet &	ORG
admet-1622	573	5	11(1	CARDINAL
admet-1622	573	6	2023	CARDINAL
admet-1622	573	7	33	CARDINAL
admet-1622	573	8	3d	CARDINAL
admet-1622	573	9	65	CARDINAL
admet-1622	573	10	martinez	PERSON
admet-1622	573	11	a. buanz	PERSON
admet-1622	573	12	a.w. basit	PERSON
admet-1622	573	13	s. gaisford	PERSON
admet-1622	574	1	3d	CARDINAL
admet-1622	575	1	international journal of pharmaceutics	ORG
admet-1622	575	2	494	CARDINAL
admet-1622	575	3	2015	CARDINAL
admet-1622	575	4	657	CARDINAL
admet-1622	576	1	66	CARDINAL
admet-1622	576	2	s. palekar	PERSON
admet-1622	576	3	p.k. nukala	GPE
admet-1622	576	4	mishra	PERSON
admet-1622	576	5	t. kipping	PERSON
admet-1622	576	6	k. patel	PERSON
admet-1622	577	1	3d	CARDINAL
admet-1622	578	1	international journal of pharmaceutics	ORG
admet-1622	578	2	556	CARDINAL
admet-1622	578	3	2019	CARDINAL
admet-1622	578	4	106	CARDINAL
admet-1622	579	1	67	CARDINAL
admet-1622	579	2	v. raje	PERSON
admet-1622	579	3	s. palekar	PERSON
admet-1622	579	4	s. banella	PERSON
admet-1622	579	5	k. patel	PERSON
admet-1622	580	1	3d	CARDINAL
admet-1622	581	1	14	CARDINAL
admet-1622	581	2	2022	CARDINAL
admet-1622	581	3	2192	DATE
admet-1622	582	1	68	CARDINAL
admet-1622	582	2	a. melocchi	PERSON
admet-1622	582	3	f. briatico-vangosa	PERSON
admet-1622	582	4	m. uboldi	PERSON
admet-1622	582	5	f. parietti	PERSON
admet-1622	582	6	m. turchi	PERSON
admet-1622	582	7	d. von zeppelin	PERSON
admet-1622	582	8	a. maroni	PERSON
admet-1622	582	9	l. zema	PERSON
admet-1622	582	10	a. gazzaniga	PERSON
admet-1622	582	11	a. zidan	PERSON
admet-1622	583	1	3d	CARDINAL
admet-1622	584	1	international journal of pharmaceutics	ORG
admet-1622	584	2	592	CARDINAL
admet-1622	584	3	2021) 119901	DATE
admet-1622	585	1	69	CARDINAL
admet-1622	585	2	t. parikh	PERSON
admet-1622	585	3	h.k. sandhu	PERSON
admet-1622	585	4	t.t. talele	GPE
admet-1622	585	5	a. serajuddin	PERSON
admet-1622	587	1	33	CARDINAL
admet-1622	587	2	2016	CARDINAL
admet-1622	589	1	70	CARDINAL
admet-1622	589	2	a. shah	PERSON
admet-1622	589	3	a. serajuddin	PERSON
admet-1622	589	4	595-611	CARDINAL
admet-1622	590	1	71	CARDINAL
admet-1622	590	2	s. singh	GPE
admet-1622	590	3	t. parikh	GPE
admet-1622	590	4	h.k. sandhu	PERSON
admet-1622	590	5	n.h. shah	GPE
admet-1622	590	6	a.w. malick	PERSON
admet-1622	590	7	d. singhal	PERSON
admet-1622	590	8	a. serajuddin	PERSON
admet-1622	592	1	30	CARDINAL
admet-1622	592	2	1561-1573	DATE
admet-1622	594	1	72	CARDINAL
admet-1622	594	2	serajuddin	ORG
admet-1622	596	1	59	CARDINAL
admet-1622	596	2	2007	DATE
admet-1622	596	3	603	CARDINAL
admet-1622	597	1	73	CARDINAL
admet-1622	597	2	serajuddin	GPE
admet-1622	597	3	c.i.	GPE
admet-1622	597	4	jarowski	PERSON
admet-1622	599	1	74	DATE
admet-1622	599	2	1985	DATE
admet-1622	599	3	142	CARDINAL
admet-1622	600	1	74	CARDINAL
admet-1622	600	2	t. parikh	PERSON
admet-1622	600	3	a. serajuddin	PERSON
admet-1622	602	1	35	CARDINAL
admet-1622	602	2	2018	DATE
admet-1622	602	3	1	CARDINAL
admet-1622	604	1	75	CARDINAL
admet-1622	604	2	j. aho	PERSON
admet-1622	604	3	j.p.	GPE
admet-1622	604	4	n. genina	PERSON
admet-1622	604	5	m. edinger	PERSON
admet-1622	604	6	l. arnfast	PERSON
admet-1622	604	7	j. rantanen	PERSON
admet-1622	604	8	3d	CARDINAL
admet-1622	605	1	108	CARDINAL
admet-1622	605	2	2019	CARDINAL
admet-1622	605	3	26	CARDINAL
admet-1622	606	1	76	CARDINAL
admet-1622	606	2	https://www.fda.gov/media/70936/download	LANGUAGE
admet-1622	606	3	november 12	DATE
admet-1622	606	4	2022	CARDINAL
admet-1622	607	1	77	CARDINAL
admet-1622	607	2	dressman	PERSON
admet-1622	607	3	g.l. amidon	PERSON
admet-1622	607	4	c. reppas	GPE
admet-1622	607	5	v.p. shah.	PERSON
admet-1622	609	1	15	CARDINAL
admet-1622	609	2	1998	DATE
admet-1622	609	3	11	CARDINAL
admet-1622	610	1	2023	CARDINAL
admet-1622	610	2	iapc	ORG
admet-1622	610	3	zagreb	GPE
admet-1622	610	4	croatia	GPE
admet-1622	611	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-1622	611	2	https://doi.org/10.3390/pharmaceutics14102192	NORP